CD248 and neoplasm: The specificity of CD248 expression for tumor endothelium in vivo was confirmed by an independent study by St Croix et al., who used serial analysis of gene expression (SAGE) technology to identify CD248 as being specifically upregulated in the endothelium of colon, lung, liver, and brain tumors [15].